| Viju Philip Deenadayalu, MD | |
|
1111 Ne 99th Ave, Portland, OR 97220-9428 | |
| (503) 963-2707 | |
| (503) 963-2802 |
| Full Name | Viju Philip Deenadayalu |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 22 Years |
| Location | 1111 Ne 99th Ave, Portland, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922270735 | NPI | - | NPPES |
| 242524 | Medicaid | OR | |
| 8512311 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD28326 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Portland Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oregon Clinic Pc | 2860390408 | 319 |
News Archive
NaviNet, America's largest real-time healthcare communications network, announces that Timothy Mills, senior vice president, provider operations, will speak about how healthcare providers can maximize reimbursement in a post-CDH world, at the MGMA 2009 Annual Conference, held in Denver, Colorado from October 11-14, 2009.
Researchers have found that two proteins which work in tandem in the brain's blood vessels present a double whammy in Alzheimer's disease.
Vertex Pharmaceuticals Incorporated today announced interim results from an ongoing Phase 2 study designed to assess the safety and tolerability of 12-week response-guided treatment regimens with its polymerase inhibitor, VX-222, and its protease inhibitor, telaprevir, in combination with pegylated-interferon and ribavirin in people with genotype 1 chronic hepatitis C who were new to treatment.
Investigators at the National Institutes of Health and international colleagues have identified a genetic immune disorder characterized by increased susceptibility and poor immune control of Epstein-Barr virus (EBV) and, in some cases, an EBV-associated cancer called Hodgkin's lymphoma.
› Verified 2 days ago
| Entity Name | Oregon Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265417174 PECOS PAC ID: 2860390408 Enrollment ID: O20031222000096 |
News Archive
NaviNet, America's largest real-time healthcare communications network, announces that Timothy Mills, senior vice president, provider operations, will speak about how healthcare providers can maximize reimbursement in a post-CDH world, at the MGMA 2009 Annual Conference, held in Denver, Colorado from October 11-14, 2009.
Researchers have found that two proteins which work in tandem in the brain's blood vessels present a double whammy in Alzheimer's disease.
Vertex Pharmaceuticals Incorporated today announced interim results from an ongoing Phase 2 study designed to assess the safety and tolerability of 12-week response-guided treatment regimens with its polymerase inhibitor, VX-222, and its protease inhibitor, telaprevir, in combination with pegylated-interferon and ribavirin in people with genotype 1 chronic hepatitis C who were new to treatment.
Investigators at the National Institutes of Health and international colleagues have identified a genetic immune disorder characterized by increased susceptibility and poor immune control of Epstein-Barr virus (EBV) and, in some cases, an EBV-associated cancer called Hodgkin's lymphoma.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Viju Philip Deenadayalu, MD 541 Ne 20th Ave Ste 225, Portland, OR 97232-2895 Ph: (503) 963-2801 | Viju Philip Deenadayalu, MD 1111 Ne 99th Ave, Portland, OR 97220-9428 Ph: (503) 963-2707 |
News Archive
NaviNet, America's largest real-time healthcare communications network, announces that Timothy Mills, senior vice president, provider operations, will speak about how healthcare providers can maximize reimbursement in a post-CDH world, at the MGMA 2009 Annual Conference, held in Denver, Colorado from October 11-14, 2009.
Researchers have found that two proteins which work in tandem in the brain's blood vessels present a double whammy in Alzheimer's disease.
Vertex Pharmaceuticals Incorporated today announced interim results from an ongoing Phase 2 study designed to assess the safety and tolerability of 12-week response-guided treatment regimens with its polymerase inhibitor, VX-222, and its protease inhibitor, telaprevir, in combination with pegylated-interferon and ribavirin in people with genotype 1 chronic hepatitis C who were new to treatment.
Investigators at the National Institutes of Health and international colleagues have identified a genetic immune disorder characterized by increased susceptibility and poor immune control of Epstein-Barr virus (EBV) and, in some cases, an EBV-associated cancer called Hodgkin's lymphoma.
› Verified 2 days ago
Salona Shrestha, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4805 Ne Glisan St, Portland, OR 97213 Phone: 503-215-2392 | |
Dr. Emmanuel Trungtoan Tavan, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2800 N Vancouver Ave, Suite 230, Portland, OR 97227 Phone: 503-413-2901 | |
Ginevra Lois Liptan, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 6400 Sw Canyon Ct, Ste 100, Portland, OR 97221 Phone: 503-477-9616 Fax: 503-477-9808 | |
Donald Richard Sullivan, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Uhn67, Portland, OR 97239 Phone: 503-494-6949 | |
Dr. Victor Nguyen Pham, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9205 Sw Barnes Rd, Portland, OR 97225 Phone: 503-216-2906 | |
Richa Uppal, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 800 Sw 13th Ave, Portland, OR 97205 Phone: 503-221-0161 Fax: 503-274-1697 | |
Reem Hasan, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Ppv 350, Portland, OR 97239 Phone: 503-494-8562 |